Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

GSK 4348413A

Next Previous
Drug Profile

GSK 4348413A

Alternative Names: Gonorrhoea vaccine - GSK ; GSK-4348413; GSK-4348413A; Neisseria gonorrhoeae generalised modules for membrane antigens vaccine - GSK; Neisseria Gonorrhoeae GMMA vaccine - GSK; Ng GMMA vaccine - GSK; NgG vaccine - GSK

Latest Information Update: 26 Aug 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator GlaxoSmithKline
  • Developer GSK
  • Class Bacterial vaccines; Conjugate vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Gonorrhoea

Most Recent Events

  • 22 May 2025 GSK completes a phase-I/II trial in Gonorrhoea (Prevention) in USA, United Kingdom, Spain, South Africa, Philippines, Germany, France, and Brazil (IM) (NCT05630859)
  • 06 Feb 2024 Phase-II clinical trials in Gonorrhoea (Prevention) (IM) (GlaxoSmithKline pipeline, February 2024)
  • 26 Jul 2023 GSK 4348413A receives Fast Track designation for Gonorrhoea [IM] (Prevention, In adults) in USA, before July 2023

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top